{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:31:11Z","timestamp":1784003471826,"version":"3.55.0"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA228524"],"award-info":[{"award-number":["R01CA228524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000869","name":"Susan G. Komen for the Cure","doi-asserted-by":"publisher","award":["KG090860"],"award-info":[{"award-number":["KG090860"]}],"id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Most breast cancer patients die due to bone metastasis. Although metastasis accounts for 5% of the breast cancer cases, it is responsible for most of the deaths. Sometimes even before the detection of a primary tumor, most of the patients have bone and lymph node metastasis. Moreover, at the time of death, breast cancer patients have the bulk of the tumor burden in their bones. Therapy options are available for the treatment of primary tumors, but there are minimal options for treating breast cancer patients who have bone metastasis. C-X-C motif chemokine receptor type 2 (CXCR2) receptor-mediated signaling has been shown to play a critical role during bone-related inflammations and its ligands C-X-C motif chemokine ligand 6 (CXCL6) and 8 (CXCL8) aid in the resorption of bone during bone metastasis. In this study, we tested the hypothesis that CXCR2 contributes to mammary tumor-induced osteolysis and bone metastasis. In the present study, we examined the role of both tumor cell-derived and host-derived CXCR2 in influencing mammary tumor cell bone metastasis. For understanding the role of tumor cell-derived CXCR2, we utilized Cl66 CXCR2 knockdown (Cl66-shCXCR2) and Cl66-Control cells (Cl66-Control) and observed a significant decrease in tumor growth and tumor-induced osteolysis in Cl66-shCXCR2 cells in comparison with the Cl66-Control cells. Next, for understanding the role of host-derived CXCR2, we utilized mice with genomic knockdown of CXCR2 (Cxcr2\u2212\/\u2212) and injected Cl66-Luciferase (Cl66-Luc) or 4T1-Luciferase (4T1-Luc) cells. We observed decreased bone destruction and metastasis in the bone of Cxcr2\u2212\/\u2212 mice. Our data suggest the importance of both tumor cell- and host-derived CXCR2 signaling in the bone metastasis of breast cancer cells.<\/jats:p>","DOI":"10.3390\/ijms20051237","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T04:07:37Z","timestamp":1552450057000},"page":"1237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis"],"prefix":"10.3390","volume":"20","author":[{"given":"Bhawna","family":"Sharma","sequence":"first","affiliation":[{"name":"Gilead Biosciences, Foster City, CA 94404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan C.","family":"Nannuru","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals Inc., Terrytown, NY 10591, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4226-9318","authenticated-orcid":false,"given":"Sugandha","family":"Saxena","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-5845, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Varney","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5845, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-5845, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/14656560902834961","article-title":"Therapeutic options for metastatic breast cancer","volume":"10","author":"Morris","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: Causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1158\/1078-0432.CCR-04-0812","article-title":"Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival","volume":"10","author":"Benoy","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_5","first-page":"82","article-title":"Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients","volume":"48","author":"Kozlowski","year":"2003","journal-title":"Rocz. Akad. Med. Bialymst."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(98)00128-8","article-title":"Chemokines and their role in tumor growth and metastasis","volume":"220","author":"Wang","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The Chemokine Superfamily Revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1044-5323(02)00127-6","article-title":"Chemokine biology in cancer","volume":"15","author":"Balkwill","year":"2003","journal-title":"Semin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/1477-3163.92308","article-title":"Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis","volume":"10","author":"Nannuru","year":"2011","journal-title":"J. Carcinog."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1535-7163.MCT-12-0529","article-title":"Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis","volume":"12","author":"Sharma","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10585-014-9691-0","article-title":"Host Cxcr2-dependent regulation of mammary tumor growth and metastasis","volume":"32","author":"Sharma","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_13","first-page":"436","article-title":"CXCR1\/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-kappaB","volume":"17","author":"Wu","year":"2017","journal-title":"Curr. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2015.12.011","article-title":"Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells","volume":"372","author":"Sharma","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.blo.0000093844.72468.f4","article-title":"Breast cancer metastasis to bone: It is not all about PTHrP","volume":"415","author":"Bendre","year":"2003","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.27470","article-title":"Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model","volume":"62","author":"Jacobs","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2009.12.025","article-title":"Pharmacological targeting reveals distinct roles for CXCR2\/CXCR1 and CCR2 in a mouse model of arthritis","volume":"391","author":"Min","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcb.21172","article-title":"Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2","volume":"101","author":"Ringe","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molmed.2010.01.003","article-title":"Chemokines and chemokine receptors: New insights into cancer-related inflammation","volume":"16","author":"Lazennec","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10549-012-2196-0","article-title":"Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production","volume":"135","author":"Shi","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood-2008-09-178301","article-title":"Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption","volume":"114","author":"Chakravarti","year":"2009","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/labinvest.2013.5","article-title":"CXCL5 stimulation of RANK ligand expression in Paget\u2019s disease of bone","volume":"93","author":"Sundaram","year":"2013","journal-title":"Lab. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI46134","article-title":"PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target","volume":"121","author":"Li","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10585-015-9714-5","article-title":"Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer","volume":"32","author":"Hardaway","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/1471-2407-11-304","article-title":"A Cross-Species Analysis of a Mouse Model of Breast Cancer-Specific Osteolysis and Human Bone Metastases Using Gene Expression Profiling","volume":"11","author":"Sadanandam","year":"2011","journal-title":"Bmc Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12282-013-0439-5","article-title":"Animal model for mammary tumor growth in the bone microenvironment","volume":"20","author":"Futakuchi","year":"2013","journal-title":"Breast Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1535370213520110","article-title":"Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases","volume":"239","author":"Boppana","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.8036519","article-title":"Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog","volume":"265","author":"Cacalano","year":"1994","journal-title":"Science"},{"key":"ref_30","first-page":"1399","article-title":"Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor","volume":"52","author":"Aslakson","year":"1992","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2009.06.035","article-title":"Cathepsin G-mediated enhanced TGF-[beta] signaling promotes angiogenesis via upregulation of VEGF and MCP-1","volume":"288","author":"Wilson","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2011.04.018","article-title":"Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor","volume":"308","author":"Halpern","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ajpath.2016.07.024","article-title":"CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma","volume":"186","author":"Kasashima","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_34","first-page":"283","article-title":"Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts","volume":"62","author":"Saad","year":"2002","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lau, Y.S., Danks, L., Sun, S.G., Fox, S., Sabokbar, A., Harris, A., and Athanasou, N.A. (2006). RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Breast Cancer Res. Treat.","DOI":"10.1007\/s10549-006-9438-y"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1158\/1078-0432.CCR-04-2420","article-title":"Angiogenesis in the bone marrow of patients with breast cancer","volume":"11","author":"Green","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1096\/fj.01-0813com","article-title":"Persistence of microscopic human cancers in mice: Alterations in the angiogenic balance accompanies loss of tumor dormancy","volume":"16","author":"Udagawa","year":"2002","journal-title":"Faseb J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","article-title":"Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: A randomized, placebo-controlled clinical trial","volume":"42","author":"Nair","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 Axis in Cancer and Inflammatory Diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1158\/0008-5472.CAN-07-5889","article-title":"Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand","volume":"68","author":"Wilson","year":"2008","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/5\/1237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:38:07Z","timestamp":1760186287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/5\/1237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijms20051237"],"URL":"https:\/\/doi.org\/10.3390\/ijms20051237","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]}}}